METHOD DEVELOPMENT AND VALIDATION OF NOVEL ANALYTICAL METHODS FOR DACLATASVIR IN BULK AND PHARMACEUTICAL FORMULATIONS USING UPLC TECHNIQUE
Shaik Mohammed Yusuf*, M. Purushothaman and A. Srikanth
A novel UPLC method proves to be simple, linear, precise, accurate, robust, rugged, and specific. A simple
accurate, precise rapid isocratic RP-UPLC method development for the estimation of Daclatasvir is a tablet dosage
form useful for routine quality control. The chromatographic system was carried on Acquity BEH C18 (50×3.0mm
×1.7μm id) using mobile phase consisting a mixture of 0.1% Orthophosphoric acid: Acetonitrile (60:40) v/v with
detection of 248 nm. The retention time of Daclatasvir was found to be 1.190min. Calibration curve was linear over
the concentration range of 50-150 μg/mL of Daclatasvir. The correlation coefficient for peak was found to be
0.9996. All the analytical validation parameters were determined and found in the limit as per ICH guidelines.
UPLC methods were simple, highly sensitive, precise and accurate, suggesting that the developed methods are
useful for routine quality control.
Keywords: Accurate, Daclatasvir, RP-UPLC, Acquity BEH column, ICH guidelines.
[Full Text Article]